Sophie Shulman

20 stories about Sophie Shulman
מימין עמירם שחר עמרי לימור ו סער אנקונינה מייסדי חברת הסייבר אפווינד Upwind

Cyber unicorn Upwind acquires nine-month-old Aegis for tens of millions

23.09.26|Sophie Shulman
The Israeli cloud security company is folding the startup into a new AI security lab focused on protecting AI agents and AI-driven workflows. 
עובדי UltraSigh אולטרה-סייט

UltraSight raises $24 million to tackle shortage of cardiac imaging specialists

23.09.26|Sophie Shulman
The Israeli startup’s AI platform enables trained medical staff to perform echocardiograms and is already installed in intensive care units at more than 10 medical facilities.
אסנת ולינגרד תנהל את קרן ההשקעות החדשה של אייבקס

Ibex raises $87 million for new Israel-focused secondary fund

23.09.26|Sophie Shulman
The U.S. investment firm is targeting liquidity opportunities in growth-stage Israeli companies as founders, employees and early investors seek to sell shares before an IPO or acquisition. 
מימין מיכאל כגן ג'נסן הואנג נתי דניאל

Nvidia establishes Israeli research group focused on AI for medicine and science

23.09.26|Sophie Shulman
The Applied AI Architecture group has begun recruiting researchers in Israel and will work on AI applications ranging from genomics and drug discovery to new materials. 
מייסדי cyera מימין יונתן איתי תמר בר אילן ו יותם שגב

Cyera raises $400 million from Goldman Sachs, bringing 2026 funding to $1.4 billion

22.09.26|Sophie Shulman, CTech
The latest investment extends Cyera’s Series G and comes as the Israeli cybersecurity company expands from data security into AI agents and non-human identities, with a valuation of more than $12 billion.
מנהלי רילסנס וקוגנקס

Intel let RealSense go. Now Cognex is paying $600 million to buy it

22.09.26|Sophie Shulman
The Haifa-based robotics company grew rapidly after its spinout 14 months ago, and its CEO says independence allowed it to pursue opportunities that would have been difficult to develop inside Intel. 
בניין חברת טבע בכפר סבא לצד מנכ"ל טבע ריצ'רד פרנסיס

Teva’s comeback is real. The harder part is still ahead

22.09.26|Sophie Shulman
The company has cleaned up its balance sheet and rebuilt its pipeline, but investors are still waiting to see whether the new strategy can deliver sustained growth.
הטכנלוגיה של פייז מדיקל

Israeli medtech company FIZE Medical raises $20 million to advance AI-guided ICU care

17.09.26|Sophie Shulman
The Series B, co-led by Asahi Kasei Medical and Rapha Capital, will accelerate development of a platform designed to predict fluid-related risks in critically ill patients. 
ערן ברק איתי שוורץ ו הוד בן נון מייסדי חברת הסייבר מיינד MIND

“Our next milestone will be a billion-dollar valuation”: MIND triples valuation to $300 million with $72 million Series B

17.09.26|Sophie Shulman
MIND has raised $112 million to date and reached a $10 million annual revenue run rate just 18 months after beginning to sell its product, as demand for data loss prevention grows with the adoption of GenAI and AI agents.  
גונן פינק פאלו אלטו נטוורקס

The man who helped build Palo Alto’s Cortex is leaving the company

16.09.26|Sophie Shulman
Gonen Fink is stepping down after a decade at the cybersecurity giant, ending his tenure as head of its Israeli R&D center.
מייסדי לורה, רועי מור (משמאל) ויונתן (יונתי) לוין

Sayeret Matkal veterans raise $22 million to teach the world English with AI

16.09.26|Sophie Shulman
Loora says its app has more than 15 million users and annual recurring revenue in the tens of millions of dollars. 
מימין סם אלטמן OpenAI דריו אמודיי אנתרופיק אלון מאסק גרוק

Why are AI’s biggest winners suddenly warning about the dangers of winning?

15.09.26|Sophie Shulman
Dario Amodei, Sam Altman and Elon Musk have all called for a slower pace of AI development, leaving investors to weigh genuine safety concerns against the enormous costs and valuations built into the AI boom. 
שיבן רמג'י מנכ"ל סלברייט

Cellebrite to reincorporate in the U.S.

14.09.26|Sophie Shulman
The $2.8 billion digital intelligence company says the move will strengthen its position in the U.S., its largest geographic market, and broaden its investor base, while its Israeli operations are expected to continue as usual.
Buildots founders

Buildots raises $130 million at nearly $1 billion valuation as AI boom drives data center construction

14.09.26|Sophie Shulman
The Israeli construction software company has more than quadrupled its valuation from its previous funding round and now has over 400 employees. Its AI system is increasingly being used on massive data center projects, where delays can carry particularly high financial costs.
Anthem

Secretive defense startup Covenant emerges from stealth with $250 million at over $1 billion valuation

09.09.26|Sophie Shulman
The startup, founded in 2024, has spent two years operating in near-total secrecy as it develops Anthem, a long-range heavy-payload weapon designed to be produced at a fraction of the cost of comparable legacy systems, with serial production expected to begin in 2027.
דור כנפו שותף בקרן ההון סיכון סייברסטארטס ו גילי רענן שותף מייסד בקרן

Cyberstarts is looking for another Tel Aviv tower to house its growing startup empire

07.09.26|Sophie Shulman
After leasing 15 floors at Landmark B for a shared campus for its portfolio companies, the $1.4 billion cybersecurity fund is now exploring options for a second location. 
מייסדי וונדרפול בר וינקלר ו רועי ללזר

Wonderful is growing like Wiz, but its business is very different

06.09.26|Sophie Shulman
The Israeli AI startup has reached a $5 billion valuation and a $70 million revenue run rate in less than two years, but its economics look far less like those of a traditional software company.
דשא. "כמי שבאה מהעולם החברתי, לקח לי קצת זמן לעכל את תעשיית ההייטק. עד שלבסוף הבנתי שבמהות שלי גם אני יזמת ואוהבת חדשנות"

An unlikely AI founder is trying to fix one of medicine’s most human problems

04.09.26|Sophie Shulman
Galit Desheh had no background in computer science when she founded Ozz Health. Drawing on a career in trauma, gender and empathy, she is developing an AI system intended to help patients understand what is happening to them and feel more in control.
ניקש ארורה מנכ"ל פאלו אלטו

Palo Alto’s CEO invested in the startup his company just bought for $500 million

03.09.26|Sophie Shulman
Console was valued at $157 million in its latest funding round before Palo Alto acquired it for a reported $500 million. Nikesh Arora was among the startup’s early investors, alongside Joshua Kushner’s Thrive Capital, which led both of its funding rounds.